General Dynamics Corporation vs Relay Therapeutics Inc. Common Stock — how do they compare? General Dynamics Corporation trades at $331.32 (market cap $88.37B), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.94B). The key difference: General Dynamics Corporation is far larger — about 22.4× Relay Therapeutics Inc. Common Stock's market cap, and General Dynamics Corporation pays a 1.95% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Dynamics Corporation for 85 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| GD | RLAY | |
|---|---|---|
Market Cap | $88.37B | $3.94B |
Volume | 1,251,409 | 3,432,928 |
Sector | Industrials | Health |
52-Week High | $395.97 | $20.75 |
52-Week Low | $312.53 | $6.03 |
Typical Hold Time | 85 Days | 0 Days |
Enterprise Value | $93.52B | $3.06B |
Dividend Yield | 1.95% | — |
Signals from Pluang's Aura AI — not financial advice
General Dynamics (GD) trades at $329.90, down 0.43% with bearish technical signals despite strong fundamentals. The defense contractor shows consistent revenue growth to $52.55B in 2025 and has beaten earnings estimates for three consecutive quarters. Analyst consensus remains strongly bullish with a $420.57 price target, while technical indicators show oversold conditions with RSI at 11.03.
GD offers solid value with reasonable valuation multiples and strong defense contract visibility, though near-term technical weakness and dependence on government spending create volatility. The stock's 27% upside to consensus target and consistent dividend payments provide attractive total return potential for long-term investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →